Climb Bio
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Climb Bio and other ETFs, options, and stocks.About CLYM
Climb Bio, Inc. operates as a clinical-stage biotechnology company. The firm develops therapeutics for patients with immune-mediated diseases.
CLYM Key Statistics
Stock Snapshot
As of today, Climb Bio(CLYM) shares are valued at $12.47. The company's market cap stands at 760.03M, with a P/E ratio of -16.01.
On 2026-08-05, Climb Bio(CLYM) stock moved within a range of $12.15 to $12.76. With shares now at $12.47, the stock is trading +2.7% above its intraday low and -2.3% below the session's peak.
Trading volume for Climb Bio(CLYM) stock has reached 1.1M, versus its average volume of 973.53K.
The stock's 52-week range extends from a low of $1.54 to a high of $14.42.
The stock's 52-week range extends from a low of $1.54 to a high of $14.42.
Analyst ratings
100%
of 16 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.